Fair Value Calculator Fair Value Calculator
EN DE

Radix Industries (India) Limited (RADIXIND) Fair Value & Analysis

Consumer Defensive · IN · Market cap ₹2.5B

RI Radix Industries (India) Limited RADIXIND · BSE
Price₹165.65
Fair Value₹36.22
Upside-78.1%
Quality62/100
Watch Radix Industries (India) Limited for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹27.16 – ₹56.38

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price −11.9% over the past month.

Price vs Fair Value (12 months)

₹215.65 ₹153.65 Fair Value ₹36.22 Jul 2025 Jul 2026

12‑month range ₹153.65 – ₹215.65 · fair‑value band ₹27.16 – ₹56.38 · the ₹165.65 price screens above the ₹36.22 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Radix Industries (India) Limited (RADIXIND) currently trades at ₹165.65, while our model-based Fair Value estimate is ₹36.22 — implying the stock looks roughly 78.1% overvalued today. We read business quality at 62/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, Radix Industries (India) Limited generated revenue of ₹505M at a net margin of 6.3%. Revenue grew 5.2% year over year. It earns a return on equity of 14.5%. Net debt stands at ₹3.5M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹27.16 (bear case) to ₹56.38 (bull case); at ₹165.65, the current price sits above that range. The share trades about 27% below its 52-week high and 9% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -47% fair-value upside — at -78%, RADIXIND screens richer than that median.

Key figures & financial health

Revenue (TTM) ₹505M
Revenue growth (YoY) +5.2%
Net margin 6.3%
Return on equity 14.5%
Free cash flow ₹65.6M FY2026
P/E ratio 77.4
More key figures
Operating margin 3.6%
EPS (TTM) ₹2.14
Dividend yield 0.3%
EPS growth (YoY) -33.2%
Net debt ₹3.5M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

About the company

Radix Industries (India) Limited engages in the manufacture and sale of human hair products in India. It offers Remy human hair in various styles and colors; and products in clip, virgin, and eminent collection categories. The company also exports its products. Radix Industries (India) Limited was incorporated in 1993 and is based in Tanuku, India.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Radix Industries (India) Limited reported revenue of ₹505M in FY2026 versus ₹248M in FY2022, a compound +19.5%/yr. Reported net income was ₹32.0M in FY2026, compounding +20.7%/yr from FY2022.

Revenue +19.5%/yr
FY22 ₹248M
FY23 ₹259M
FY24 ₹329M
FY25 ₹483M
FY26 ₹505M
Net income +20.7%/yr
FY22 ₹15.1M
FY23 ₹15.3M
FY24 ₹22.3M
FY25 ₹26.3M
FY26 ₹32.0M

Is RADIXIND fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Radix Industries (India) Limited Fair Value". https://www.fairvalue-calculator.com/stock/RADIXIND

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG 2,590 MXN 108.66 MXN -96%
L'Oréal S.A LRLCF $445.77 $275.67 -38%
Unilever PLC UNLYF $59.34 $46.11 -22%
Colgate-Palmolive Company CPA €77.60 €36.69 -53%
Hindustan Unilever Limited HINDUNILVR ₹2,122 ₹677.55 -68%
Reckitt Benckiser Group RBGLY $12.32 $17.37 +41%
Henkel AG HENOY $20.52 $20.98 +2%
Kimberly-Clark Corporation KMBB34 R$530.90 R$72.97 -86%
Kenvue Inc KVUE $17.71 $9.38 -47%
Church & Dwight Co CHDC34 R$488.56 R$243.53 -50%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Radix Industries (India) Limited (RADIXIND) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹36.22 versus a price of ₹165.65 — about −78% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RADIXIND?
Our model-based fair value for Radix Industries (India) Limited is ₹36.22 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹165.65.
What is the quality score of RADIXIND?
Radix Industries (India) Limited has a Quality Score of 62/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Radix Industries (India) Limited (RADIXIND)?
Radix Industries (India) Limited reported trailing-twelve-month revenue of about ₹505M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of RADIXIND?
The net profit margin of Radix Industries (India) Limited is about 6.3%, meaning it keeps roughly 6.3% of revenue as net income. Based on the latest reported figures.
Does Radix Industries (India) Limited pay a dividend?
Radix Industries (India) Limited currently shows a dividend yield of about 0.29% relative to its recent price (as of Jul 5, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.